Biotech/Pharma Patents in India: Data & 3(d) Considerations
Almost 70% of pharma patents in India get the thumbs down because of one pesky rule. Call it Section 3(d) of the Indian Patents Act of … Read More
Almost 70% of pharma patents in India get the thumbs down because of one pesky rule. Call it Section 3(d) of the Indian Patents Act of … Read More